Clinical Trial Update: A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) [Phase 3]

View source ↗

Summary

Phase 3 trial of rovalpituzumab tesirine as maintenance therapy after first-line platinum-based chemotherapy in extensive-stage small cell lung cancer was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• rovalpituzumab tesirine (rovalpituzumab tesirine)

Snippet

Sponsor: AbbVie | Conditions: Small Cell Lung Cancer | Phase 3 | Status: TERMINATED | Results posted: 2020-12-21